MwanzoAPN • JSE
add
Aspen Pharmacare Holdings Ltd
Bei iliyotangulia
ZACÂ 15,739.00
Bei za siku
ZACÂ 15,610.00 - ZACÂ 16,449.00
Bei za mwaka
ZACÂ 14,141.00 - ZACÂ 25,296.00
Thamani ya kampuni katika soko
73.03B ZAR
Wastani wa hisa zilizouzwa
1.72M
Uwiano wa bei na mapato
16.23
Mgao wa faida
2.19%
Ubadilishanaji wa msingi
JSE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (ZAR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 10.98B | 3.87% |
Matumizi ya uendeshaji wa biashara | 3.28B | 12.84% |
Mapato halisi | 1.19B | 3.20% |
Kiwango cha faida halisi | 10.87 | -0.73% |
Mapato kwa kila hisa | — | — |
EBITDA | 2.47B | 11.05% |
Asilimia ya kodi ya mapato | 25.02% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (ZAR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 6.80B | -41.33% |
Jumla ya mali | 136.60B | -1.93% |
Jumla ya dhima | 51.51B | -4.06% |
Jumla ya hisa | 85.09B | — |
hisa zilizosalia | 444.10M | — |
Uwiano wa bei na thamani | 0.82 | — |
Faida inayotokana na mali | 3.56% | — |
Faida inayotokana mtaji | 4.04% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (ZAR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 1.19B | 3.20% |
Pesa kutokana na shughuli | 902.50M | -26.57% |
Pesa kutokana na uwekezaji | -1.40B | 54.76% |
Pesa kutokana na ufadhili | 479.50M | -75.45% |
Mabadiliko halisi ya pesa taslimu | -208.00M | -427.56% |
Mtiririko huru wa pesa | 155.00M | 185.99% |
Kuhusu
Aspen Pharmacare Holdings Limited is a public multinational pharmaceutical company headquartered in uMhlanga, South Africa. Founded in 1997, it listed on the Johannesburg Stock Exchange in 1998, and purchased South African Druggists in 1999 before expanding into international markets. Currently the largest pharmaceutical company in Africa through aggressive mergers and expansion, with major manufacturing sites in locations such as Gqeberha in South Africa, Bad Oldesloe in Germany, Notre-Dame-de-Bondeville in France, and Oss, Netherlands, Aspen is known for manufacturing and distributing branded pharmaceuticals as well as generic HIV/AIDS antiretrovirals and cancer medications. Among other products, Aspen has also been involved in manufacturing the Janssen COVID-19 vaccine through "fill and finish", and has the rights to sell the product under its own brand name Aspenovax. The company's revenue in 2022 was R38.6 billion. In 2016 Aspen was fined for high prices on cancer drugs, and after an investigation Aspen committed to reduce prices for 5 years in the European Union. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1850
Makao Makuu
Tovuti
Wafanyakazi
9,109
